Phase 3 FINCH 1 and FINCH 3 Data of Filgotinib in Rheumatoid Arthritis to Be Featured in Opening Plenary and Late Breaker Sessions Foster City Calif. and Mechelen Belgium; May 29 2019; 22.30 CET Gilead Sciences Inc. NASDAQ GILD and Galapagos NV Eurone...
↧